Treatment
Treatment A clinical trials
We’re tracking 8,310 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT07404787Recruiting
Suicide prevention telehealth program for soldiers after hospital stay
This trial tests a telehealth case management program to help prevent suicide among soldiers recently discharged from a psychiatric hospital. If you are an active duty soldier who has been hospitalized for mental health reasons and have access to a phone and computer, this program may provide extra support during your recovery.
Bethesda, MarylandAges 18 years+ - NCT07406152Recruiting
A gel for hard-to-heal chronic wounds
This study tests a new gel and applicator for chronic wounds that are hard to heal, like bed sores, diabetic foot ulcers, and leg ulcers. The goal is to see if the gel helps wounds heal safely.
Vitoria-Gasteiz, ÁlavaAges 18 years+ - NCT07406035RecruitingPhase 2
Study of TQH3906 for active psoriatic arthritis
This trial tests an experimental oral medication called TQH3906 for people with active psoriatic arthritis (PsA), a condition that causes joint pain, swelling, and skin psoriasis. The study aims to see if TQH3906 is safe and effective in reducing arthritis symptoms.
Bozhou, AnhuiAges 18–70 - NCT07403266RecruitingPhase 3
Full-spectrum cannabis oil for seizures in tuberous sclerosis
This trial tests a full-spectrum cannabis extract to see if it reduces seizures in people with tuberous sclerosis complex (TSC) whose seizures have not been controlled by other treatments. If it works, it could offer a new option for managing hard-to-treat epilepsy.
MadridAges 2–65 - NCT07404969Recruiting
Integrative medicine for unexplained infertility after treatment
This trial studies whether combining traditional Chinese medicine with standard care can help women with unexplained infertility after previous treatments. It looks at aging markers in your blood to see if they affect your chances of getting pregnant.
NeuchâtelAges 25–42 - NCT07399028Recruiting
Skin changes from biostimulator treatment in women
This study looks at how a biostimulator (a type of injectable treatment that helps your skin produce more collagen) changes your skin. Researchers will use special cameras and scans to see these changes, which may help reduce wrinkles on your cheeks.
New York, New YorkAges 45–65 - NCT07405398Recruiting
Smartwatch study to detect opioid use and withdrawal
This study uses a smartwatch to track wrist data and help detect when someone is using opioids or experiencing withdrawal. It's designed for people with opioid use disorder who are starting or already on treatment with methadone or buprenorphine.
Wilmington, North CarolinaAges 22 years+ - NCT07400757Recruiting
Statin and vitamin D for active thyroid eye disease
This trial tests whether a statin (a cholesterol-lowering medicine) combined with vitamin D can improve active thyroid eye disease. It may help if you have both eye inflammation and high cholesterol.
Taipei, TaiwanAges 20 years+ - NCT07401524RecruitingPhase 4
Carbetocin to prevent bleeding after twin delivery
This trial tests whether a medication called carbetocin can help prevent heavy bleeding after giving birth to twins. If you are pregnant with twins and at least 23 weeks along, you may be able to join.
Ramat GanAges 18 years+ - NCT07400809Recruiting
Cervical cancer with limited spread: a study on treatment results
This study looks at women with cervical cancer that has spread to only a few places (oligo-metastatic) or come back in a few places (oligo-recurrent). It hopes to understand how well treating those spots with radiation or other local treatments works, even if you've already had treatment before.
Mumbai, MaharashtraAges Any age - NCT07401498Enrolling by invitation
Studying side effects of lymph node removal in lung cancer surgery
This trial looks at complications from removing lymph nodes during surgery for non-small cell lung cancer. It may help doctors understand how to make surgery safer.
UlyanovskAges 18 years+ - NCT03647098Recruiting
Lung cancer survival study for adults receiving study treatment
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
Changsha, HunanAges 18 years+ - NCT06162338Recruiting
Study of LY-M001 for Gaucher Disease Type I
This study tests an injection called LY-M001 for adults with Gaucher disease type I. The goal is to see if it can safely help replace the missing enzyme and improve symptoms.
Hanzhou, ZhejiangAges 18–60 - NCT07398326RecruitingPhase 2
Drug combo for advanced colorectal cancer that hasn't spread to the liver
This trial tests a combination of two drugs (anlotinib and sintilimab) as a first treatment for people with advanced colorectal cancer that has spread to places other than the liver, who do not want chemotherapy. The goal is to see if this targeted therapy can help control the cancer.
ShanghaiAges 18 years+ - NCT07402031Recruiting
Predicting weight loss from obesity treatments
This study looks at how people lose weight after medication or surgery for obesity. It helps predict which treatment might work best for you.
Brussels, Brussels CapitalAges 18–65 - NCT07401420Recruiting
Study on life-sustaining treatments in critically ill children
This study asks experienced critical care doctors about decisions they make when providing life-sustaining treatments to critically ill children, especially around end-of-life care. Your insights could help improve how these difficult situations are handled.
GothenburgAges 18 years+ - NCT07402512RecruitingPhase 3
Study of deuremidevir for RSV in infants and young children
This trial is testing a new medicine called deuremidevir for babies and young children with RSV infection. It is for those who have symptoms like fast breathing and wheezing, and have been sick for no more than 96 hours.
Xiamen, FujianAges 1 month–3 years - NCT07400536RecruitingPhase 3
Cadonilimab plus chemo and radiation for advanced cervical cancer
This trial tests a new immunotherapy drug, cadonilimab, combined with standard chemotherapy followed by chemoradiation for locally advanced cervical cancer. The goal is to see if this combination works better than current treatments.
Wuhan, HubeiAges 18–70 - NCT07405086RecruitingPhase 4
Morning versus afternoon immunotherapy for advanced cancer
This trial tests whether getting your immunotherapy infusion in the morning or in the afternoon makes any difference in how well it works. If you have certain types of advanced cancer and are about to start a standard FDA-approved immunotherapy, this study may help you and others by finding the best time of day for treatment.
Portland, OregonAges 18 years+ - NCT07405905Recruiting
Comparing mini implant placements for fixing upper teeth overbite
This study tests two ways of placing small temporary anchors (mini implants) in the jaw to help pull upper front teeth back into a better position. It is for patients who have finished growing and have a Class II overbite, to see which anchor location works best.
Rohtak, HaryanaAges 18–30 - NCT07406139RecruitingPhase 4
PCC treatment for hemophilia A with inhibitors
This trial tests a clotting factor product called PCC (prothrombin complex concentrate) to treat bleeding episodes in people with hemophilia A who have developed inhibitors. It's for those who are 12–65 and have frequent joint bleeds.
Tianjin, Tianjin MunicipalityAges 12–65 - NCT07400783Recruiting
Study of short bowel syndrome in children
This study looks at short bowel syndrome in children who have had intestinal surgery. It may help doctors understand how to better treat this condition.
Florence, FlorenceAges 4 months–17 years - NCT07400510Enrolling by invitation
Ultrasound for DVT diagnosis and treatment
This trial uses a bedside ultrasound to quickly diagnose deep vein thrombosis (DVT) and help guide treatment. It may help patients who have symptoms like leg swelling or pain.
Hershey, PennsylvaniaAges 18 years+ - NCT07398677Recruiting
SchoolCare: Helping kids with cancer stay connected to school
This study tests if a telepresence robot and a school navigator can help children with cancer stay engaged with their school during long treatments. It aims to reduce school disruption and social isolation.
AalborgAges 5–17
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,310 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.